Sandbox: sadaf: Difference between revisions

Jump to navigation Jump to search
Ssharfaei (talk | contribs)
Ssharfaei (talk | contribs)
No edit summary
Line 177: Line 177:
| align="center" style="background:#F5F5F5;" | −
| align="center" style="background:#F5F5F5;" | −
| align="center" style="background:#F5F5F5;" | −
| align="center" style="background:#F5F5F5;" | −
| align="center" style="background:#F5F5F5;" | +/-
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" | +/-
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" | ↑
| align="center" style="background:#F5F5F5;" | ↑
| align="center" style="background:#F5F5F5;" | Normal or ↑
| align="center" style="background:#F5F5F5;" | Normal or ↑
Line 216: Line 216:
| align="center" style="background:#F5F5F5;" | −
| align="center" style="background:#F5F5F5;" | −
| align="center" style="background:#F5F5F5;" | −
| align="center" style="background:#F5F5F5;" | −
| align="center" style="background:#F5F5F5;" | Normal/
| align="center" style="background:#F5F5F5;" | Normal or
| align="center" style="background:#F5F5F5;" | ↑
| align="center" style="background:#F5F5F5;" | ↑
| align="center" style="background:#F5F5F5;" | Normal
| align="center" style="background:#F5F5F5;" | Normal
Line 277: Line 277:
| align="center" style="background:#F5F5F5;" | <nowiki>+</nowiki>
| align="center" style="background:#F5F5F5;" | <nowiki>+</nowiki>
| align="center" style="background:#F5F5F5;" | <nowiki>+</nowiki>
| align="center" style="background:#F5F5F5;" | <nowiki>+</nowiki>
| align="center" style="background:#F5F5F5;" | +/-
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" | +/-
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" | Normal/
| align="center" style="background:#F5F5F5;" | Normal or
| align="center" style="background:#F5F5F5;" | ↑
| align="center" style="background:#F5F5F5;" | ↑
| align="center" style="background:#F5F5F5;" | Normal
| align="center" style="background:#F5F5F5;" | Normal
Line 286: Line 286:
| align="center" style="background:#F5F5F5;" | −
| align="center" style="background:#F5F5F5;" | −
|-
|-
! colspan="2" align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Von Willebrand disease|Von Willebrand Disease]]<span name="harr_c115s002s005p001"></span><span name="9100810"></span> <ref name="pmid25196510">{{cite journal |vauthors=Elbatarny M, Mollah S, Grabell J, Bae S, Deforest M, Tuttle A, Hopman W, Clark DS, Mauer AC, Bowman M, Riddel J, Christopherson PA, Montgomery RR, Rand ML, Coller B, James PD |title=Normal range of bleeding scores for the ISTH-BAT: adult and pediatric data from the merging project |journal=Haemophilia |volume=20 |issue=6 |pages=831–5 |date=November 2014 |pmid=25196510 |pmc=4251588 |doi=10.1111/hae.12503 |url=}}</ref>
! colspan="2" align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Von Willebrand disease|Von Willebrand Disease]]<span name="harr_c115s002s005p001"></span><span name="9100810"></span>  
| align="left" style="background:#F5F5F5;" |  
| align="left" style="background:#F5F5F5;" |  
* Easy bruising
* Easy bruising
Line 298: Line 298:
| align="center" style="background:#F5F5F5;" | <nowiki>+</nowiki>
| align="center" style="background:#F5F5F5;" | <nowiki>+</nowiki>
| align="center" style="background:#F5F5F5;" | <nowiki>+</nowiki>
| align="center" style="background:#F5F5F5;" | <nowiki>+</nowiki>
| align="center" style="background:#F5F5F5;" | +/-
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" | +/-
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" | ↑
| align="center" style="background:#F5F5F5;" | ↑
| align="center" style="background:#F5F5F5;" | Normal
| align="center" style="background:#F5F5F5;" | Normal
Line 324: Line 324:
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+/-</nowiki>
|±
| -
|
| -
|
|Normal
|Normal
|↑/Normal
|↑/Normal
Line 332: Line 332:
|Normal
|Normal
|Normal
|Normal
|<nowiki>-</nowiki>
|
|-
|-
! align="center" style="padding: 5px 5px; background: #DCDCDC;" |Inherited Disorders of the [[Vessel wall|Vessel Wall]]
! align="center" style="padding: 5px 5px; background: #DCDCDC;" |Inherited Disorders of the [[Vessel wall|Vessel Wall]]
Line 342: Line 342:
|
|
* Positive family history
* Positive family history
|<nowiki>-</nowiki>
|
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+/-</nowiki>
|±
| -
|
| -
|
|Normal
|Normal
|↑/Normal
|↑/Normal
Line 353: Line 353:
|Normal
|Normal
|Normal
|Normal
|<nowiki>-</nowiki>
|
|-
|-
! rowspan="12" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Coagulation factor disorders
! rowspan="12" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Coagulation factor disorders
Line 380: Line 380:
* [[Cerebral hemorrhage]]
* [[Cerebral hemorrhage]]
* [[Thrombosis]]
* [[Thrombosis]]
|<nowiki>-</nowiki>
|
| -
|
| +
| +
| +
| +
| +/-
|±
| +
| +
|Normal
|Normal
Line 406: Line 406:
* [[Hemarthrosis]]
* [[Hemarthrosis]]
* [[Intracranial hemorrhage|Intracranial]] bleeding
* [[Intracranial hemorrhage|Intracranial]] bleeding
|
|
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
Line 417: Line 417:
|↑
|↑
|↑
|↑
|<nowiki>-</nowiki>
|
|-
|-
! colspan="3" rowspan="1" align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Factor V deficiency]]
! colspan="3" rowspan="1" align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Factor V deficiency]]
Line 427: Line 427:
* [[Intracerebral hemorrhage|Intracerebral hemorrhages]]
* [[Intracerebral hemorrhage|Intracerebral hemorrhages]]
* [[Pulmonary hemorrhage]]  
* [[Pulmonary hemorrhage]]  
|
|
|_
|_
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
Line 485: Line 485:
|↑
|↑
|Normal
|Normal
|<nowiki>-</nowiki>
|
|-
|-
! colspan="3" rowspan="1" align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Factor XII|Factor XII deficiency]]
! colspan="3" rowspan="1" align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Factor XII|Factor XII deficiency]]
Line 543: Line 543:
|
|
* Possibility of positive family history of bleeding
* Possibility of positive family history of bleeding
| -/+
|±
| -/+
|±
|<nowiki>-/+</nowiki>
|±
|<nowiki>-/+</nowiki>
|±
|<nowiki>-/+</nowiki>
|±
|<nowiki>-/+</nowiki>
|±
|Normal
|Normal
|Normal
|Normal
Line 568: Line 568:
* [[Epistaxis]]
* [[Epistaxis]]
* [[Gingival bleeding]]
* [[Gingival bleeding]]
| -
|
| -
|
| -
|
| +
| +
| +
| +
Line 579: Line 579:
|↑
|↑
|Normal
|Normal
|<nowiki>-</nowiki>
|
|-
|-
! colspan="2" align="center" style="padding: 5px 5px; background: #DCDCDC;" |Type B deficiency
! colspan="2" align="center" style="padding: 5px 5px; background: #DCDCDC;" |Type B deficiency
Line 587: Line 587:
* [[Hemarthrosis]]   
* [[Hemarthrosis]]   
* [[Hematoma|Hematomas]]  
* [[Hematoma|Hematomas]]  
| -
|
| -
|
| -
|
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
| +
| +
Line 598: Line 598:
|↑
|↑
|Normal
|Normal
|<nowiki>-</nowiki>
|
|-
|-
! colspan="2" align="center" style="padding: 5px 5px; background: #DCDCDC;" |Type C deficiency
! colspan="2" align="center" style="padding: 5px 5px; background: #DCDCDC;" |Type C deficiency
Line 604: Line 604:
* Family history  
* Family history  
* Bleeding after surgery or injury
* Bleeding after surgery or injury
| -
|
| -
|
| -
|
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|Rare
|Rare
Line 615: Line 615:
|↑
|↑
|Normal
|Normal
| -
|
|-
|-
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Rare diseases
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Rare diseases
Line 638: Line 638:
|↑
|↑
|Normal
|Normal
| -
|
|-
|-
! colspan="3" align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Vitamin K Deficiency]]
! colspan="3" align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Vitamin K Deficiency]]
Line 652: Line 652:
* Easy [[Bruise|bruisability]]
* Easy [[Bruise|bruisability]]
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
| -
|
| +
| +
| +
| +
Line 662: Line 662:
|Normal or mildly prolonged
|Normal or mildly prolonged
|Normal
|Normal
| -
|
|}
|}
Different types of Von-Willebrand diseases can be differentiated from each other based on the following table:
Different types of Von-Willebrand diseases can be differentiated from each other based on the following table:

Revision as of 15:57, 19 October 2018

Differential Diagnosis

Different causes of the bleeding disorders can be differentiated based on their clinical manifestation and laboratory findings.

These features have discussed in the below table:

Category Sub-category Diseases History Clinical manifestation Laboratory testing Comments
Mucosal bleeding Petechia Ecchymoses Menorrhagia Hematoma Hemarthrosis Platelet count Bleeding time (BT) Prothrombin time (PT) Activated partial thromboplastin time (aPTT) Thrombin time (TT)
Platelet disorders Thrombocytopenia Infection-Induced thrombocytopenia
  • History of prior infection
+ + + + + + Normal Normal Normal
Medications-Induced thrombocytopenia + + + + + + Normal Normal Normal Most important part of treatment is discontinuing of the medication.
Heparin-Induced thrombocytopenia + + + + + + Normal Normal For more information click here: Heparin-induced thrombocytopenia.
Immune Thrombocytopenic Purpura (ITP) + + + + + + Normal Normal Normal
Inherited Thrombocytopenia
  • Positive family history
+ + + + + + Normal Normal Normal
Thrombotic Thrombocytopenic Purpura (TTP) History of: + + + + + + Normal Normal Normal
Hemolytic Uremic Syndrome History of: + + + + + + Normal Normal Normal
Thromobcytosis Iron deficiency anemia

Inflammatory diseases

Splenectomy

Essential thrombocytosis

± ± Normal or ↑ Normal Normal Normal
Qualitative Disorders of Platelet Function Inherited Disorders of Platelet Function Glanzmann’s thrombasthenia
  • Positive family history
+ + + + Rare Normal or ↓ Normal Normal Normal
  • AR inheritance
  • Absence of the platelet Gp IIb/IIIa receptor
  • Diminished for GP 2B-3A on flow cytometry
Bernard-Soulier syndrome
  • Positive family history
+ + + + Normal or ↓ Normal Normal Normal
  • AR inheritance
  • Absence of the platelet Gp Ib-IX-V receptor
  • On PBS: giant platelets
  • Ristocetin - no aggregation
Wiskott-Aldrich syndrome
  • Positive family history
+ + + + Normal or ↓ Normal Normal Normal
  • Anti-WASP antibody can be used to detect presence or absence of WAS protein
  • In Wiskott–Aldrich syndrome, the platelets are small and do not function properly. They are removed by the spleen, which leads to low platelet counts.
Platelet storage pool disorder (SPD): + + + + Normal or ↓ Normal Normal Normal
  • AD inheritance
  • Abnormalities of platelet granule formation
Acquired Disorders of Platelet Function + + + + ± ± Normal or ↓ Normal Normal Normal
Von Willebrand Disease + + + + ± ± Normal Normal See the table below for the details about different types.
Vessel wall disorders Metabolic and Inflammatory Disorders
  • History of the underlying disease.
+ + ± Normal ↑/Normal Normal Normal Normal
Inherited Disorders of the Vessel Wall
  • Positive family history
+ + ± Normal ↑/Normal Normal Normal Normal
Coagulation factor disorders

[1]

Fibrinogen deficiency Different types of the fibrinogen disorders: + + ± + Normal
  • Impaired fibrin cross linking or clot dissolution.
  • The severity of bleeding in patients with fibrinogen disorders can be mild or severe, with higher bleeding risk in those with afibrinogenemia or lower levels of functional fibrinogen. The age of onset is also variable, with earlier onset in those with more severe deficiency.
Prothrombin deficiency + + + + + Normal Normal
Factor V deficiency _ + + + + Normal Normal The severity of bleeding is only partly related to the degree of factor V deficiency. Some patients with undetectable plasma levels of factor V experience only relatively mild bleeding.
Factor VII deficiency + + + Normal Normal Normal Thrombosis occurs in inherited factor VII deficiency most cases are associated with the administration of factor VII replacement therapy
Factor X deficiency
  • Prolonged bleeding following circumcision
+ + + + + Normal Normal Normal
Factor XII deficiency
  • Majority,asymptomatic
  • Recurrent miscarriages
  • Painful leg ulcers
_ _ _ _ _ Normal Normal Normal Normal
High molecular weight kininogen (HMWK) deficiency
  • Possibility of positive family history of bleeding
_ _ _ _ _ Normal Normal Normal Normal
Prekallikrein deficiency
  • Possibility of positive family history of bleeding
_ _ _ _ _ Normal Normal Normal Normal
Factor XIII deficiency Types:
  • Sub unit A mutation disease (more common)
  • Sub unit B mutation disease
  • Possibility of positive family history of bleeding
± ± ± ± ± ± Normal Normal Normal/↑ Normal Normal
  • Impaired fibrin cross linking or clot dissolution
  • The severity of factor XIII deficiency bleeds can be different in different patients
Hemophilia Type A deficiency + + + Normal Normal Normal Normal
Type B deficiency + + + Normal Normal Normal Normal
Type C deficiency
  • Family history
  • Bleeding after surgery or injury
+ Rare Rare Normal Normal Normal Normal
Rare diseases Disseminated Intravascular Coagulation + + + + + + Normal
Vitamin K Deficiency + + + + + Normal Normal or mildly prolonged Normal

Different types of Von-Willebrand diseases can be differentiated from each other based on the following table:

Type of VWD Type of factor deficiency Prevalence Inheritance pattern Clinical manifestations VWF activity RIPA Factor VIII
Type 1 Quantitative/ partial 60-70% AD
  • Bleeding severity mild to severe
Type 2 2A Qualitative 10% AD/AR N or ↓
2B Qualitative 5% AD N or ↓
2M Qualitative <1% AD/AR N or ↓
2N Qualitative <1% AR N N
Type 3 Complete deficiency 1-2% AR Absent Low, 1-10%

For more information on Von Willebrand disease, click here.

  1. Invalid <ref> tag; no text was provided for refs named pmid28966616